{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T18:29:03Z","timestamp":1788114543815,"version":"build-2803163510"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aimed to evaluate the safety profile of sevoflurane in pediatric populations using real-world data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data were extracted from the Food and Drug Administration Adverse Event Reporting System (FAERS) from the first quarter of 2004 to the third quarter of 2024. We analyzed reports where sevoflurane was the primary suspect in individuals aged 0\u201318, employing disproportionality analysis to detect adverse events associated with sevoflurane. We also compared the adverse events related to sevoflurane between pediatric and adult populations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The FAERS database yielded 21,838,627 adverse event reports for children, with 474 involving sevoflurane as the primary suspect. Descriptive analysis revealed a majority of reports from male patients, primarily reported by physicians. Disproportionality analysis identified significant System Organ Classes (SOC) signals associated with sevoflurane, meeting four detection criteria, including \u201cCardiac disorders,\u201d \u201cRespiratory, thoracic, and mediastinal disorders,\u201d and \u201cVascular disorders.\u201d The study also identified previously unreported adverse events, such as \u201cEncephalopathy\u201d and \u201cHypercapnia.\u201d Notable differences in signals were observed between children and adults for \u201cPulmonary alveolar hemorrhage,\u201d \u201cAnaphylactic shock,\u201d and \u201cHypotension.\u201d<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our analysis of the FAERS database identified several significant adverse events associated with sevoflurane in pediatrics, affecting the cardiovascular, respiratory, and nervous systems. Differences in adverse event signals between children and adults were also observed. Furthermore, the new adverse events (such as encephalopathy and hypercapnia) indicated that anesthesiologists should be more vigilant in administering sevoflurane.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1548376","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T06:51:27Z","timestamp":1739170287000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Safety profiles of sevoflurane in pediatric patients: a real-world pharmacovigilance assessment based on the FAERS database"],"prefix":"10.3389","volume":"16","author":[{"given":"Chuang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangjian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.22551\/2023.38.1001.10235","article-title":"Sevoflurane-induced diffuse alveolar hemorrhage","volume":"10","author":"Ahmed-Khan","year":"2023","journal-title":"Arch. Clin. Cases"},{"key":"B2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/aco.0b013e32832972f3","article-title":"Pediatric laryngospasm: prevention and treatment","volume":"22","author":"Al-alami","year":"2009","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/bja\/aer094","article-title":"Effect of patient sex on general anaesthesia and recovery","volume":"106","author":"Buchanan","year":"2011","journal-title":"Br. J. Anaesth."},{"key":"B4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/BF03011308","article-title":"Airway irritation produced by volatile anaesthetics during brief inhalation: comparison of halothane, enflurane, isoflurane and sevoflurane","volume":"40","author":"Doi","year":"1993","journal-title":"Can. J. Anaesth."},{"key":"B5","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1097\/00000542-199404000-00024","article-title":"New inhaled anesthetics","volume":"80","author":"Eger","year":"1994","journal-title":"Anesthesiology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1032","DOI":"10.1097\/MJT.0000000000000321","article-title":"Network meta-analysis on the efficacy of dexmedetomidine, midazolam, ketamine, propofol, and fentanyl for the prevention of sevoflurane-related emergence agitation in children","volume":"23","author":"Fang","year":"2016","journal-title":"Am. J. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/00000542-200408000-00034","article-title":"Acute respiratory distress syndrome after an exothermic Baralyme-sevoflurane reaction","volume":"101","author":"Fatheree","year":"2004","journal-title":"Anesthesiology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/pan.14840","article-title":"The halothane era in pediatric anesthesia: the convergence of a cardiac depressant anesthetic with the immature myocardium of infancy","volume":"34","author":"Friesen","year":"2024","journal-title":"Paediatr. Anaesth."},{"key":"B9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s10194-024-01858-4","article-title":"Post-marketing safety concerns with rimegepant based on a pharmacovigilance study","volume":"25","author":"Hu","year":"2024","journal-title":"J. Headache Pain"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e1161","DOI":"10.1002\/prp2.1161","article-title":"Is pitolisant safe for clinical use? A retrospective pharmacovigilance study focus on the post-marketing safety","volume":"12","author":"Jiang","year":"2024","journal-title":"Pharmacol. Res. Perspect."},{"key":"B11","doi-asserted-by":"publisher","first-page":"20813","DOI":"10.1074\/jbc.M801944200","article-title":"Reduced threshold for luminal Ca2+ activation of RyR1 underlies a causal mechanism of porcine malignant hyperthermia","volume":"283","author":"Jiang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1213\/01.ANE.0000154534.71371.4F","article-title":"The influence of gender on loss of consciousness with sevoflurane or propofol","volume":"101","author":"Kodaka","year":"2005","journal-title":"Anesth. Analg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s00101-002-0340-7","article-title":"Anaesthetic management for endoscopy of the pediatric airway","volume":"51","author":"Machotta","year":"2002","journal-title":"Anaesthesist"},{"key":"B14","doi-asserted-by":"publisher","first-page":"bcr2017222010","DOI":"10.1136\/bcr-2017-222010","article-title":"Postoperative diffuse alveolar haemorrhage: insidious negative pressure or sevoflurane induced?","volume":"2018","author":"Mersh","year":"2018","journal-title":"BMJ Case Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40981-016-0043-8","article-title":"Transient cardiac arrest in a child with Down syndrome during anesthesia induction with sevoflurane: a case report","volume":"2","author":"Nogami","year":"2016","journal-title":"JA Clin. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"951","DOI":"10.23736\/S0375-9393.19.13077-5","article-title":"Sevoflurane sedation for weaning from mechanical ventilation in pediatric intensive care unit","volume":"85","author":"Pavcnik","year":"2019","journal-title":"Minerva Anestesiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1034\/j.1399-6576.2003.00036.x","article-title":"Gender differences in drug effects: implications for anesthesiologists","volume":"47","author":"Pleym","year":"2003","journal-title":"Acta Anaesthesiol. Scand."},{"key":"B18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","article-title":"Malignant hyperthermia: a review","volume":"10","author":"Rosenberg","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1007\/pl00002497","article-title":"Sevofluran in der Kinderan\u00e4sthesie. Maligne Hyperthermie [Sevoflurane in pediatric anesthesia. Malignant hyperthermia]","volume":"47","author":"Scholz","year":"1998","journal-title":"Anaesthesist"},{"key":"B21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1177\/0885066617713169","article-title":"An unusual complication with the administration of a volatile anesthetic agent for status asthmaticus in the pediatric intensive care unit: case report and review of the literature","volume":"32","author":"Shutes","year":"2017","journal-title":"J. Intensive Care Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1213\/00000539-199308000-00014","article-title":"Malignant hyperthermia: a review of published cases","volume":"77","author":"Strazis","year":"1993","journal-title":"Anesth. Analg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"9018624","DOI":"10.1155\/2020\/9018624","article-title":"Resveratrol mitigates sevoflurane-induced neurotoxicity by the SIRT1-dependent regulation of BDNF expression in developing mice","volume":"2020","author":"Tang","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrn.2016.128","article-title":"Lasting impact of general anaesthesia on the brain: mechanisms and relevance","volume":"17","author":"Vutskits","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ijporl.2015.11.007","article-title":"Sevoflurane and bradycardia in infants with trisomy 21: a case report and review of the literature","volume":"80","author":"Walia","year":"2016","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1097\/ALN.0000000000003522","article-title":"Early childhood general anesthesia and neurodevelopmental outcomes in the avon longitudinal study of parents and children birth cohort","volume":"133","author":"Walkden","year":"2020","journal-title":"Anesthesiology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1213\/00000539-197511000-00021","article-title":"Sevoflurane: a new inhalational anesthetic agent","volume":"54","author":"Wallin","year":"1975","journal-title":"Anesth. Analg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.36085\/pain.v25i3.1567606","article-title":"Multimodal analgesia with sevoflurane provides enhanced intraoperative analgesic effects in percutaneous nephrolithotomy: a randomized, blinded clinical trial","volume":"25","author":"Wang","year":"2022","journal-title":"Pain Physician"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1391356","DOI":"10.3389\/fphar.2024.1391356","article-title":"Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)","volume":"15","author":"Wen","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40360-024-00815-w","article-title":"Real-world research on beta-blocker usage trends in China and safety exploration based on the FDA Adverse Event Reporting System (FAERS)","volume":"25","author":"Yan","year":"2024","journal-title":"BMC Pharmacol. Toxicol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"19555","DOI":"10.1038\/s41598-022-23834-1","article-title":"A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib","volume":"12","author":"Yin","year":"2022","journal-title":"Sci. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s12264-022-00825-w","article-title":"Estrogen receptor-A in medial preoptic area contributes to sex difference of mice in response to sevoflurane anesthesia","volume":"38","author":"Zhang","year":"2022","journal-title":"Neurosci. Bull."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1338902","DOI":"10.3389\/fphar.2024.1338902","article-title":"Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database","volume":"15","author":"Zou","year":"2024","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1548376\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T06:51:30Z","timestamp":1739170290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1548376\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":33,"alternative-id":["10.3389\/fphar.2025.1548376"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1548376","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"article-number":"1548376"}}